Learning objectives: Provide a summary of regulatory pathways that may be used to make products available in emergency situations.

Summarize the characteristics of the available COVID-19 vaccines.

Session date: 
10/19/2021 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Peter W. Marks, MD, PhD